Biomarker candidates for progression and clinical management of COVID-19 associated pneumonia at time of admission

COVID-19 pathophysiology is currently not fully understood, reliable prognostic factors remain elusive, and few specific therapeutic strategies have been proposed. In this scenario, availability of biomarkers is a priority. MS-based Proteomics techniques were used to profile the proteome of 81 plasm...

Descripción completa

Detalles Bibliográficos
Autores principales: Calvet, Joan, Berenguer-Llergo, Antoni, Gay, Marina, Massanella, Marta, Domingo, Pere, Llop, Maria, Sánchez-Jiménez, Ester, Arévalo, Marta, Carrillo, Jorge, Albiñana, Néstor, Arauz-Garofalo, Gianluca, Orellana, Cristóbal, Delgado, Juan Francisco, Serrano, Alejandra, Llobell, Artur, Graell, Eduard, García-Manrique, María, Moreno, Mireia, Galisteo, Carlos, Casado, Enrique, Navarro, Noemí, Gómez, Antoni, Garcia-Cirera, Silvia, Rusiñol, Menna, Costa, Ester, Clotet, Bonaventura, Vilaseca, Marta, Blanco, Julià, Gratacós, Jordi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8755735/
https://www.ncbi.nlm.nih.gov/pubmed/35022497
http://dx.doi.org/10.1038/s41598-021-04683-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8755735/
https://www.ncbi.nlm.nih.gov/pubmed/35022497
http://dx.doi.org/10.1038/s41598-021-04683-w

Ejemplares similares